ADDENTAX GROUP CORP.
For the period ended Mar 31, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)Financial Statements
We have filed the financial statements in Item 8. Financial Statements and Supplementary Data as a part of this Annual Report on Form 10-K.
(b)Exhibits
The following is a list of all exhibits filed or incorporated by reference as part of this annual report on Form 10-K.
| Exhibit · Filed or Furnished · Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Number · Herewith · Form · Exhibit · Date · File No. | ||||||
| 3.1 | Articles of Incorporation | S-1 | 3.1 | 8/5/2015 | 333-206097 | |
| 3.2 | Certificate of Amendment Pursuant to NRS 78.386 and 78.390, effectuating the two for one forward stock split and increasing the authorized shares of common stock of Addentax Group Corp. from 75,000,000 to 150,000,000 | 8-K | 3.1 | 7/21/2016 | 333-206097 | |
| 3.3 | Certificate of Amendment Pursuant to NRS 78.385 and 78.390, increasing the authorized shares of common stock of Addentax Group Corp. to 1,000,000,000 | S-1 | 3.3 | 4/18/2019 | 333-230943 | |
| 3.4 | Certificate of Change Pursuant to NRS 78.209, effectuating the 20-for-1 reverse stock split and decreasing the authorized shares of common stock of Addentax Group Corp. from 1,000,000,000 to 50,000,000 | 8-K | 3.1 | 3/5/2019 | 333-206097 | |
| 3.5 | Amended and Restated Bylaws | 8-K | 3.1 | 3/15/2019 | 333-206097 | |
| 3.6 | Certificate of Amendment to the Amended and Restated Articles of Incorporation increasing the authorized shares of common stock of Addentax Group Corp. to 250,000,000 | 8-K | 3.1 | 3/23/2023 | 001-41478 | |
| 3.7 | Amendment to the Articles of Incorporation, as amended, of Addentax Group Corp. for 1-for-10 Reverse Stock Split | 8-K | 3.1 | 6/30/2023 | 001-41478 | |
| 3.9 | Stamped copy of the Certificate of Amendment to the Articles of Incorporation, as amended, of Addentax Group Corp. for 1-for-10 Reverse Stock Split | 8-K | 3.2 | 6/30/2023 | 001-41478 | |
| 3.10 | Stamped copy of Certificate of Correction to the Certificate of Amendment to the Articles of Incorporation, as amended, of Addentax Group Corp. for 1-for-10 Reverse Stock Split | 8-K | 3.3 | 6/30/2023 | 001-41478 | |
| 3.11 | Certificate of Amendment to the Articles of Incorporation | 8-K | 3.1 | 3/26/2026 | 001-41478 | |
| 4.1 | Description of Securities. | X | ||||
| 4.2 | Form of Senior Secured Convertible Note | 8-K | 4.1 | 1/4/2023 | ||
| 4.3 | Form of PIPE Warrant | 8-K | 10.2 | 1/4/2023 | ||
| 4.4 | Form of Placement Agent Warrant | 8-K | 10.8 | 1/4/2023 | ||
| 10.1 | Form of Subscription Agreement | S-1 | 99.1 | 8/5/2015 | 333-206097 | |
| 10.2 | Sale and Purchase Agreement for the Acquisition of 100% of the shares and assets of Yingxi Industrial Chain Group Co., Ltd.; Dated December 26, 2016 | 8-K | 10.3 | 12/28/2016 | 333-206097 | |
| 10.3 | Sale and Purchase Agreement for the Acquisition of 100% of the shares and assets of Yingxi Industrial Chain Group Co., Ltd.; Dated March 6, 2017 | 8-K | 10.4 | 3/7/2017 | 333-206097 | |
| 10.4 | Independent Director Agreement with Mr. Alex P. Hamilton | 8-K | 10.1 | 5/10/2021 | 333-206097 | |
| 10.5 | Independent Director Agreement with Mr. Li Weilin | 8-K | 10.1 | 4/29/2024 | 001-41478 | |
| 10.6 | Independent Director Agreement with Xiao Jiangping (Gary) | 8-K | 10.1 | 5/13/2021 | 333-206097 | |
| 10.7 | Securities Purchase Agreement dated January 4, 2023 | 8-K | 10.1 | 1/4/2023 | 001-41478 | |
| 10.8 | Form of Amendment No. 1 to Securities Purchase Agreement dated January 10, 2023 | 8-K | 10.1 | 1/10/2023 | 001-41478 | |
| 10.9 | Form of Registration Rights Agreement | 8-K | 10.3 | 1/4/2023 | 001-41478 | |
| 10.10 | Form of Security and Pledge Agreement | 8-K | 10.4 | 1/4/2023 | 001-41478 | |
| 10.11 | Form of Guaranty Agreement | 8-K | 10.5 | 1/4/2023 | 001-41478 | |
| 10.12 | Form of Voting Agreement | 8-K | 10.6 | 1/4/2023 | 001-41478 | |
| 10.13 | Form of Placement Agency Agreement dated January 4, 2023 | 8-K | 10.7 | 1/4/2023 | 001-41478 | |
| 10.14 | Form of Private Placement Agreement dated April 29, 2024 | 8-K | 10.1 | 4/29/2024 | 001-41478 | |
| 10.15 | Form of Private Placement Agreement dated April 29, 2024 | 8-K | 10.2 | 4/29/2024 | 001-41478 | |
| 10.16 | Form of Securities Purchase Agreement dated January 8, 2025 | 8-K | 10.1 | 1/13/2025 | 001-41478 | |
| 10.17 | 2024 Equity Incentive Plan | 10-K | 10.17 | 6/30/2025 | 001-41478 | |
| 10.18 | Share Exchange Agreement dated May 15, 2026 by and among the Company, Yingxi Industrial Chain Investment co., Ltd, Riches Family Office Limited, Riches FO Holdings Limited and Mr. Wu Rui | 8-K | 10.1 | 05/21/2026 | 001-41478 | |
| 10.19 | Share Exchange Agreement dated April 22, 2026 by and among the Company, Yingxi Industrial Chain Investment Co., Ltd, Time is Loan Limited and OR Shan Shan | 8-K | 10.1 | 04/28/2026 | 001-41478 | |
| 10.20 | Stock Purchase Agreement dated February 17, 2026 | 8-K | 10.1 | 2/19/2026 | 001-41478 | |
| 10.21 | Bond Transfer Agreement dated February 18, 2026 | 8-K | 10.2 | 2/19/2026 | 001-41478 | |
| 14.1 | Code of Ethics | 10-K/A | 14.1 | 9/21/2018 | 333-206097 | |
| 19.1 | Insider Trading Policy | 10-K | 19.1 | 6/30/2025 | 001-41478 | |
| 21.1 | Subsidiaries of the Registrant. | X | ||||
| 31.1 | Certification of Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a). | X | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a). | X | ||||
| 32.1* | Certifications by the Chief Executive Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. | X | ||||
| 32.2* | Certifications by the Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. | X | ||||
| 97.1 | Policy Relating to Recovery of Erroneously Awarded Compensation | 8-K | 99.1 | 10/25/2023 | 001-41478 | |
| 101.INS | Inline XBRL Instance Document + |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document + |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document + |
| 101.DEF | Inline XBRL Taxonomy Extension Definitions Linkbase Document + |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document + |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document + |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
X Filed herewith
*In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 herewith are deemed to accompany this Form 10-K and will not be deemed filed for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.